Keflex (cephalexin) and Bactrim (sulfamethoxazole/trimethoprim) are prescribed together to cover two different types of bacteria that can cause the same infection. This combination is most common in skin and soft tissue infections where a doctor suspects both Streptococcus and MRSA (methicillin-resistant Staphylococcus aureus) may be involved. Each antibiotic handles a pathogen the other one misses.
The Coverage Gap Each Drug Fills
Keflex is a cephalosporin antibiotic that works well against Streptococcus (the bacteria behind most standard cellulitis) and regular Staph aureus, but it does not work against MRSA. Bactrim, on the other hand, is one of the go-to drugs for MRSA, with roughly 94 to 96 percent of MRSA strains still susceptible to it based on CDC surveillance data from 2012 to 2018. But Bactrim has a weak spot: it is not considered a reliable first choice for Streptococcus infections, which are more effectively treated with beta-lactam antibiotics like Keflex.
So when a skin infection could involve either pathogen, or both, prescribing both drugs at once closes the gap. Keflex handles the strep. Bactrim handles the MRSA. Together, they provide broad coverage without needing a stronger or intravenous antibiotic.
When Doctors Typically Prescribe Both
The most common scenario is a skin infection that doesn’t clearly fall into one category. Infectious disease guidelines from IDSA distinguish between two types of skin infections: non-purulent (no pus, no abscess) and purulent (pus-filled, often around a wound or boil). Non-purulent cellulitis is usually caused by Streptococcus and treated with Keflex alone. Purulent infections are more likely caused by Staph aureus, including MRSA, and treated with Bactrim alone.
The combination tends to come into play when the picture is mixed. Maybe the infection started as simple redness and swelling but developed a draining area. Maybe there’s a wound with surrounding spreading redness. Or the patient has risk factors for MRSA (prior MRSA infection, recent hospitalization, close household contacts with MRSA) but the infection also looks like it could be streptococcal. In these gray-zone cases, covering both bacteria makes clinical sense.
How the Two Drugs Attack Bacteria Differently
These antibiotics kill bacteria through completely different mechanisms, which is part of why they pair well. Keflex targets the bacterial cell wall. It blocks an enzyme bacteria need to build and maintain their outer structure, which causes the cell to burst. Bactrim works on a totally different system: it starves bacteria of folic acid, a vitamin they need to make DNA. Bactrim actually contains two drugs that block two consecutive steps in folic acid production, making the combination especially effective at shutting down that pathway.
Because they attack through unrelated mechanisms, there’s no redundancy. They don’t compete with each other or cancel each other out. Drug interaction databases list no known interactions between the two medications.
What the Clinical Evidence Shows
For straightforward, non-purulent cellulitis (the kind without pus or an abscess), the combination doesn’t appear to offer a clear advantage over Keflex alone. A randomized trial of 500 emergency department patients with uncomplicated, non-purulent cellulitis compared a seven-day course of Keflex plus Bactrim against Keflex plus placebo. Both groups had roughly 85 percent clinical cure rates at the 14 to 21 day follow-up, with no statistically significant difference.
This makes sense biologically. If the infection is caused by Streptococcus alone, adding MRSA coverage doesn’t help because MRSA isn’t the problem. The combination becomes valuable specifically when MRSA is a real possibility, which is why doctors weigh the clinical picture before deciding on one drug versus two.
MRSA Resistance Worth Knowing About
Bactrim remains effective against the vast majority of MRSA strains, but resistance is creeping upward. CDC data shows that the proportion of MRSA isolates not susceptible to Bactrim rose from 3.6 percent in 2012 to 5.5 percent in 2018. That’s still a high success rate overall, but the trend varies by region. Some geographic areas have seen sharper increases that could affect how well Bactrim works as a first-line option. Local resistance patterns, tracked through hospital antibiograms, influence whether your doctor feels confident prescribing Bactrim for suspected MRSA.
What to Expect While Taking Both
A typical course lasts 7 to 14 days depending on the severity of the infection. Keflex is usually taken three to four times a day, while Bactrim is taken twice daily. The most common side effects of both drugs are gastrointestinal: nausea, diarrhea, and stomach discomfort. Bactrim can also cause skin rashes and increased sun sensitivity, so sun protection is a good idea during treatment. Staying well hydrated while on Bactrim helps reduce the small risk of kidney-related side effects.
Because you’re taking two antibiotics simultaneously, the chance of digestive side effects is somewhat higher than with either drug alone. Taking them with food can help. If you develop a rash, significant swelling, or difficulty breathing, those are signs of an allergic reaction that need immediate attention. People with a sulfa allergy cannot take Bactrim, and those with penicillin allergies have a small chance of cross-reactivity with Keflex, so your doctor will ask about drug allergies before prescribing this combination.
Why Not Just Use One Broader Antibiotic
You might wonder why doctors don’t just prescribe a single antibiotic that covers everything. The answer is antibiotic stewardship. Broader-spectrum antibiotics (like certain fluoroquinolones or intravenous options) kill a wider range of bacteria, including beneficial ones, and contribute more to antibiotic resistance. Using two targeted, narrower-spectrum drugs lets doctors cover the specific bacteria they’re worried about without unnecessarily wiping out everything else. It’s a more precise approach that preserves the effectiveness of stronger antibiotics for situations that truly need them.